GEN Exclusives

More »

GEN News Highlights

More »
Jul 1, 2008

Thermo Fisher Scientific Takes Over Open Biosystems

  • Thermo Fisher Scientific is acquiring Open Biosystems to expand its position in the RNAi field. Open Biosystems specializes in shRNA and viral-vector systems for delivering shRNA into living cells. The company offers shRNA libraries for human and mouse genomes.

    “The acquisition of Open Biosystems further strengthens our market-leading position in synthetic RNAi products with highly complementary technologies based on advanced shRNA,” says Marijn E. Dekkers, president and CEO of Thermo Fisher Scientific. “This combination brings together leading technologies for analyzing gene function, allowing us to create a powerful tool set for our customers who are performing cutting-edge life science research.”

    Open Biosystems also provides collections of complementary DNA and open reading frame (ORF) vectors for gene expression as well as custom antibody services for detection of changes in cellular protein levels. Open Biosystems, which reportedly had revenues of approximately $14 million in 2007, will be integrated into Thermo Fisher’s analytical technologies segment.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »